About StressMarq Biosciences

StressMarq Biosciences Inc. is a biotechnology company based in Victoria, Canada, and specializes in reagents and kits for research purposes. It is represented in over 40 countries all over the world through our strong international distributor network, selling our highly validated reagents to private and public clients alike. The company has its core expertise in two principal areas, cellular stress and ion channel and transporter research, although the company is well represented in other areas, including post-translational modifications with offerings of antibodies specific for methylation and acetylation moieties. The cellular stress area itself is represented by a core focus in the heat shock protein (HSP) area where the company is the world leader, but also engages in the oxidative stress sector. StressMarq is unparalleled in providing 4 separate product lines to address these areas – antibodies, proteins, ELISA kits and small molecules.

Facts about StressMarq Biosciences
  • Focus : Manufacturer
  • Industry : Biotechnology

Here you will find StressMarq Biosciences Inc.

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous